349 related articles for article (PubMed ID: 33982770)
21. Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.
Shin SS; Won SY; Noh DH; Hwang B; Kim WJ; Moon SK
Drug Dev Res; 2017 Mar; 78(2):81-90. PubMed ID: 28176369
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
23. Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer.
Zhu H; Chen H; Wang J; Zhou L; Liu S
Onco Targets Ther; 2019; 12():3441-3457. PubMed ID: 31123405
[No Abstract] [Full Text] [Related]
24. NCR3LG1 (B7-H6) is a potential prognostic factor for bladder cancer patients.
Zhao L; Lian T; Li J; Wei S; Li H; Li C; Wang H
Biomarkers; 2021 May; 26(3):260-267. PubMed ID: 33523715
[TBL] [Abstract][Full Text] [Related]
25. ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.
Li X; Shang D; Shen H; Song J; Hao G; Tian Y
Biomed Pharmacother; 2020 Jun; 126():110066. PubMed ID: 32172065
[TBL] [Abstract][Full Text] [Related]
26. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
27. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
[TBL] [Abstract][Full Text] [Related]
28. The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
Huang J; Lo UG; Wu S; Wang B; Pong RC; Lai CH; Lin H; He D; Hsieh JT; Wu K
Cell Death Dis; 2019 Jun; 10(6):437. PubMed ID: 31164632
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT-MDM2-p53 signaling axis.
Zhu Y; Dai B; Zhang H; Shi G; Shen Y; Ye D
Cancer Lett; 2016 Oct; 380(2):369-374. PubMed ID: 27130667
[TBL] [Abstract][Full Text] [Related]
30. Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway.
Zhu Q; Hong B; Zhang L; Wang J
J Cancer Res Ther; 2018 Sep; 14(Supplement):S616-S621. PubMed ID: 30249877
[TBL] [Abstract][Full Text] [Related]
31. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
[TBL] [Abstract][Full Text] [Related]
32. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
Dong Q; Fu L; Zhao Y; Tan S; Wang E
Oncotarget; 2017 Mar; 8(10):17059-17069. PubMed ID: 28178653
[TBL] [Abstract][Full Text] [Related]
33. PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells.
Cheng S; Qian K; Wang Y; Wang G; Liu X; Xiao Y; Wang X
J Cell Mol Med; 2019 May; 23(5):3724-3736. PubMed ID: 30912275
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
35. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
36. miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
Liu X; Kong C; Zhang Z
Oncol Rep; 2018 May; 39(5):2324-2332. PubMed ID: 29512748
[TBL] [Abstract][Full Text] [Related]
37. COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer.
Owusu-Ansah KG; Song G; Chen R; Edoo MIA; Li J; Chen B; Wu J; Zhou L; Xie H; Jiang D; Zheng S
Int J Oncol; 2019 Aug; 55(2):391-404. PubMed ID: 31268154
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of EGF-induced migration and invasion by sulfated polysaccharide of Sepiella maindroni ink via the suppression of EGFR/Akt/p38 MAPK/MMP-2 signaling pathway in KB cells.
Jiang W; Tian W; Ijaz M; Wang F
Biomed Pharmacother; 2017 Nov; 95():95-102. PubMed ID: 28830011
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway.
Fan Y; Song X; Du H; Luo C; Wang X; Yang X; Wang Y; Wu X
Med Oncol; 2014 Jul; 31(7):65. PubMed ID: 24952510
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
